Novel thrombin inhibitors

The present invention provides isolated peptides, variants and fragments thereof that are capable of binding with a high level of specificity to thrombin and inhibiting its activity. There is also provided uses of such peptides in methods of diagnosis and treatment, coating of medical devices and nucleic acids encoding same..

Medienart:

Patent

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Europäisches Patentamt - (2020) vom: 12. Nov. Zur Gesamtaufnahme - year:2020

Sprache:

Englisch

Beteiligte Personen:

IYER JANAKI KRISHNAMOORTHY [VerfasserIn]
KOH CHO YEOW [VerfasserIn]
KINI R MANJUNATHA [VerfasserIn]
KAZIMIROVA MARIA [VerfasserIn]
ROLLER LADISLAV [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07H: Sugars; derivatives thereof; nucleosides; nucleotid (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2020-11-12, Last update posted on www.tib.eu: 2023-07-04, Last updated: 2023-07-08

Patentnummer:

AU2016280365

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA010412484